COLLEEN ADKINS: Open Payments
NPI 1346690856 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 15 payments from 10 companies in 2025. Trend: 2023 $502 · 2024 $539 · 2025 $375
Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $79 |
| Janssen Biotech, Inc. | 2 | $56 |
| ABBVIE INC. | 2 | $55 |
| PFIZER INC. | 2 | $40 |
| Celgene Corporation | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| ARRAY BIOPHARMA INC | 1 | $27 |
| GENZYME CORPORATION | 1 | $22 |
| Incyte Corporation | 1 | $22 |
| SOBI, INC | 1 | $19 |
Products named: RYBREVANT, IMBRUVICA, IMFINZI, OPDIVO, SCEMBLIX, BRAFTOVI, ENHERTU, EPKINLY.
Industry payments across TX — which companies pay providers there.
